124 related articles for article (PubMed ID: 38158663)
1. The potential role of Epstein-Barr Virus in breast cancer development.
Gouadfel K; Khenchouche A; Rabea S; Mansour AA; Salem-Bekhit MM; Ouhida S; Msela A; Salem MM; Erto A; Benguerba Y; Houali K
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(13):241-249. PubMed ID: 38158663
[TBL] [Abstract][Full Text] [Related]
2. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
[TBL] [Abstract][Full Text] [Related]
3. Detection of Epstein Barr Nuclear Antigen-1 (EBNA-1), Early Antigen 1F, 2R (EA-1F, EA- 2R) along with Epstein-Barr virus Latent Membrane Protein 1 (LMP1) in Breast Cancer of Northern India: An Interim Analysis.
Shahi V; Agarwal P; Qayoom S; Kumar V; Tewari S; Raghuvanshi S; Singh US; Goel MM
Asian Pac J Cancer Prev; 2022 Nov; 23(11):3717-3723. PubMed ID: 36444584
[TBL] [Abstract][Full Text] [Related]
4. Investigation of Epstein-Barr virus in breast carcinomas in Tunisia.
Hachana M; Amara K; Ziadi S; Romdhane E; Gacem RB; Trimeche M
Pathol Res Pract; 2011 Nov; 207(11):695-700. PubMed ID: 22024152
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of EBV proteins LMP1 and BHFR1 in EBV‑associated gastric and nasopharyngeal cancer tissues.
Wang A; Zhang W; Jin M; Zhang J; Li S; Tong F; Zhou Y
Mol Med Rep; 2016 May; 13(5):4151-8. PubMed ID: 27052804
[TBL] [Abstract][Full Text] [Related]
6. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
[TBL] [Abstract][Full Text] [Related]
7. Association of Plasma Epstein-Barr Virus LMP1 and EBER1 with Circulating Tumor Cells and the Metastasis of Nasopharyngeal Carcinoma.
Sun L; Wang Y; Shi J; Zhu W; Wang X
Pathol Oncol Res; 2020 Jul; 26(3):1893-1901. PubMed ID: 31832991
[TBL] [Abstract][Full Text] [Related]
8. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the Variability of Epstein-Barr Virus Genes in Nasopharyngeal Biopsies: Potential Predictors for Carcinoma Progression.
Banko AV; Lazarevic IB; Folic MM; Djukic VB; Cirkovic AM; Karalic DZ; Cupic MD; Jovanovic TP
PLoS One; 2016; 11(4):e0153498. PubMed ID: 27071030
[TBL] [Abstract][Full Text] [Related]
10. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Epstein-Barr Virus Among Women With Breast Cancer Using Monoclonal Antibodies for Latent Membrane Protein 1 (LMP1).
Salih MM; Higgo AA; Khalifa AS; Eed EM
In Vivo; 2022; 36(3):1513-1518. PubMed ID: 35478129
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the tumor microenvironment by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.
Yoshizaki T; Kondo S; Endo K; Nakanishi Y; Aga M; Kobayashi E; Hirai N; Sugimoto H; Hatano M; Ueno T; Ishikawa K; Wakisaka N
Cancer Sci; 2018 Feb; 109(2):272-278. PubMed ID: 29247573
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.
Yu PH; Chou SF; Chen CL; Hung H; Lai CY; Yang PM; Jeng YM; Liaw SF; Kuo HH; Hsu HC; Chen JY; Wang WB
PLoS One; 2013; 8(12):e82254. PubMed ID: 24340011
[TBL] [Abstract][Full Text] [Related]
14. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
[TBL] [Abstract][Full Text] [Related]
15. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
16. Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance.
Xie L; Shi F; Li Y; Li W; Yu X; Zhao L; Zhou M; Hu J; Luo X; Tang M; Fan J; Zhou J; Gao Q; Wu W; Zhang X; Liao W; Bode AM; Cao Y
Signal Transduct Target Ther; 2020 May; 5(1):56. PubMed ID: 32433544
[TBL] [Abstract][Full Text] [Related]
17. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
Wasil LR; Wei L; Chang C; Lan L; Shair KH
J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
[TBL] [Abstract][Full Text] [Related]
18. Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy.
Hu J; Li Y; Li H; Shi F; Xie L; Zhao L; Tang M; Luo X; Jia W; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Liao W; Bode AM; Cao Y
Theranostics; 2020; 10(26):11921-11937. PubMed ID: 33204320
[TBL] [Abstract][Full Text] [Related]
19. Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis.
Shi F; He Y; Li J; Tang M; Li Y; Xie L; Zhao L; Hu J; Luo X; Zhou M; Liu N; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Jia W; Bode AM; Cao Y
Mol Metab; 2020 Jun; 36():100966. PubMed ID: 32224436
[TBL] [Abstract][Full Text] [Related]
20. Localization of Epstein-Barr virus to infiltrating lymphocytes in breast carcinomas and not malignant cells.
Khan G; Philip PS; Al Ashari M; Houcinat Y; Daoud S
Exp Mol Pathol; 2011 Aug; 91(1):466-70. PubMed ID: 21600202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]